Molecular correlates of age-dependent seizures in an inherited neonatal-infantile epilepsy
The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Abstract
Many idiopathic epilepsy syndromes have a characteristic age dependence, the underlying molecular mechanisms of which are largely unknown. Here we propose a mechanism that can explain that epileptic spells in benign familial neonatal-infantile seizures occur almost exclusively during the first days to months of life. Benign familial neonatal-infantile seizures are caused by mutations in the gene SCN2A encoding the voltage-gated Na(+) channel Na(V)1.2. We identified two novel SCN2A mutations causing benign familial neonatal-infantile seizures and analysed the functional consequences of these mutations in a neonatal and an adult splice variant of the human Na(+) channel Na(V)1.2 expressed heterologously in tsA201 cells together with beta1 and beta2 subunits. We found significant gating changes leading to a gain-of-function, such as an increased persistent Na(+) current, accelerated recovery from fast inactivation or altered voltage-dependence of steady-state activation. Those were restricted to the neonatal splice variant for one mutation, but more pronounced for the adult form for the other, suggesting that a differential developmental splicing does not provide a general explanation for seizure remission. We therefore analysed the developmental expression of Na(V)1.2 and of another voltage-gated Na(+) channel, Na(V)1.6, using immunohistochemistry and real-time reverse transcription-polymerase chain reaction in mouse brain slices. We found that Na(V)1.2 channels are expressed early in development at axon initial segments of principal neurons in the hippocampus and cortex, but their expression is diminished and they are gradually replaced as the dominant channel type by Na(V)1.6 during maturation. This finding provides a plausible explanation for the transient expression of seizures that occur due to a gain-of-function of mutant Na(V)1.2 channels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast to the developmental loss of NaV1.2 in cortical myelinated axons, NaV1.2 expression persists throughout development in the cerebellum, with an apparent peak in density within the second and third postnatal weeks in mice [22,23].”
From Progress in Understanding and Treating SCN2A-Mediated Disorders (2018) · cites this paper as [23]
Citations
Cites
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319
Control of goal-directed and stimulus-driven attention in the brain
Corbetta, M., & Shulman, G. L. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn755 · Cited by 12,881
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Imaging Cognition II: An Empirical Review of 275 PET and fMRI Studies
Cabeza, R., & Nyberg, L. (2000) · Journal of Cognitive Neuroscience · doi:10.1162/08989290051137585 · Cited by 3,598
Van Dongen, H. P. A., Maislin, G., Mullington, J. M., & Dinges, D. F. (2003) · Sleep · doi:10.1093/sleep/26.2.117 · Cited by 3,173
Region of interest analysis using an SPM toolbox
Brett, M. (2002) · NeuroImage · Cited by 2,273
Neurocognitive consequences of sleep deprivation
Goel, N., Rao, H., Durmer, J., & Dinges, D. (2009) · Seminars in Neurology · doi:10.1055/s-0029-1237117 · Cited by 2,154
Assessment of current diagnostic criteria for Guillain-Barr� syndrome
Asbury, A. K., & Cornblath, D. R. (1990) · Annals of Neurology · doi:10.1002/ana.410270707 · Cited by 1,905
Cited by
Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders
Wolff, M., Johannesen, K. M., Hedrich, U. B. S., Masnada, S., Rubboli, G., Gardella, E., Lesca, G., Ville, D., Milh, M., Villard, L., et al. (2017) · Brain · doi:10.1093/brain/awx054 · Cited by 600
Self-citationProgress in Understanding and Treating SCN2A-Mediated Disorders
Sanders, S. J., Campbell, A. J., Cottrell, J. R., Moller, R. S., Wagner, F. F., Auldridge, A. L., Bernier, R. A., Catterall, W. A., Chung, W. K., Empfield, J. R., et al. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.03.011 · Cited by 338
“2 expression persists throughout development in the cerebellum, with an apparent peak in density within the second and third postnatal weeks in mice [22,23].”
BackgroundSelf-citationBen-Shalom, R., Keeshen, C. M., Berrios, K. N., An, J. Y., Sanders, S. J., & Bender, K. J. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.01.009 · Cited by 288
“2 plays the dominant role in neuronal excitability at this age (7).”
BackgroundThe evolving spectrum of PRRT2-associated paroxysmal diseases
Ebrahimi-Fakhari, D., Saffari, A., Westenberger, A., & Klein, C. (2015) · Brain · doi:10.1093/brain/awv317 · Cited by 270
SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures
Howell, K. B., McMahon, J. M., Carvill, G. L., Tambunan, D., Mackay, M. T., Rodriguez-Casero, V., Webster, R., Clark, D., Freeman, J. L., Calvert, S., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001926 · Cited by 255
Spratt, P. W. E., Ben-Shalom, R., Keeshen, C. M., Burke, K. J., Clarkson, R. L., Sanders, S. J., & Bender, K. J. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.037 · Cited by 244
“2 in the AIS is well established (Gazina et al., 2015; Hu et al., 2009; Liao et al., 2010), there is less consensus on its distribution in pyramidal cell dendrites.”
BackgroundSodium channelopathies in neurodevelopmental disorders
Meisler, M. H., Hill, S. F., & Yu, W. (2021) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-00418-4 · Cited by 192
Clinical spectrum of SCN2A mutations expanding to Ohtahara syndrome
Nakamura, K., Kato, M., Osaka, H., Yamashita, S., Nakagawa, E., Haginoya, K., Tohyama, J., Okuda, M., Wada, T., Shimakawa, S., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a43e57 · Cited by 201
“2 channels in a population of neurons during maturation.(31) Nav1.”
BackgroundBenign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation
Gardella, E., Becker, F., Møller, R. S., Schubert, J., Lemke, J. R., Larsen, L. H. G., Eiberg, H., Nothnagel, M., Thiele, H., Altmüller, J., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24580 · Cited by 186
“6 is not expressed early on but becomes the predominant channel with increasing maturation.(30) This may explain the different onset of patients carrying either SCN2A or SCN8A mutations.”
BackgroundSelf-citationSCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain
Liao, Y., Anttonen, A.-K., Liukkonen, E., Gaily, E., Maljevic, S., Schubert, S., Bellan-Koch, A., Petrou, S., Ahonen, V. E., Lerche, H., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f8812e · Cited by 170
Self-citationClinical spectrum and genotype–phenotype associations of KCNA2-related encephalopathies
Masnada, S., Hedrich, U. B. S., Gardella, E., Schubert, J., Kaiwar, C., Klee, E. W., Lanpher, B. C., Gavrilova, R. H., Synofzik, M., Bast, T., et al. (2017) · Brain · doi:10.1093/brain/awx184 · Cited by 164
Self-citationDravet syndrome—From epileptic encephalopathy to channelopathy
Brunklaus, A., & Zuberi, S. M. (2014) · Epilepsia · doi:10.1111/epi.12652 · Cited by 161
“6, thereby rescuing channel function.(30) This might explain why children with BFNIS due to inherited SCN2Amutations generally present as neonates or infants and seizures remit spontaneously within the first year of life, whereas truncating or de novo SCN2Amissense mutations are known to be associated with more severe…”
BackgroundConvulsive seizures and SUDEP in a mouse model of SCN8A epileptic encephalopathy
Wagnon, J. L., Korn, M. J., Parent, R., Tarpey, T. A., Jones, J. M., Hammer, M. F., Murphy, G. G., Parent, J. M., & Meisler, M. H. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu470 · Cited by 158
Early onset epileptic encephalopathy caused by de novo SCN 8A mutations
Ohba, C., Kato, M., Takahashi, S., Lerman‐Sagie, T., Lev, D., Terashima, H., Kubota, M., Kawawaki, H., Matsufuji, M., Kojima, Y., et al. (2014) · Epilepsia · doi:10.1111/epi.12668 · Cited by 158
“2 in a population of excitatory neurons during maturation.(16,17) In fact, the developmental shift in splicing of SCN8A exon 18 to a transcript encoding the full length protein is still incomplete at 10 months of age.”
BackgroundWei, F., Yan, L.-M., Su, T., He, N., Lin, Z.-J., Wang, J., Shi, Y., Yi, Y., & Liao, W. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0134-1 · Cited by 164
Common variants associated with general and MMR vaccine–related febrile seizures
Feenstra, B., Pasternak, B., Geller, F., Carstensen, L., Wang, T., Huang, F., Eitson, J. L., Hollegaard, M. V., Svanström, H., Vestergaard, M., et al. (2014) · Nature Genetics · doi:10.1038/ng.3129 · Cited by 152
Johannesen, K. M., Liu, Y., Koko, M., Gjerulfsen, C. E., Sonnenberg, L., Schubert, J., Fenger, C. D., Eltokhi, A., Rannap, M., Koch, N. A., et al. (2022) · Brain · doi:10.1093/brain/awab321 · Cited by 147
Structure-based assessment of disease-related mutations in human voltage-gated sodium channels
Huang, W., Liu, M., Yan, S. F., & Yan, N. (2017) · Protein & Cell · doi:10.1007/s13238-017-0372-z · Cited by 149
“This article is published with open access at Springerlink.com and journal.hep.com.cn P ro te in & C e ll V261M, L1563V, and Y1579C) (Misra et al., 2008; Liao et al., 2010; Lauxmann et al., 2013).”
BackgroundEpilepsy-Related Voltage-Gated Sodium Channelopathies: A Review
Menezes, L. F. S., Júnior, E. F. S., Tibery, D. V., Carneiro, L. D. A., & Schwartz, E. F. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01276 · Cited by 156
“…negative shift in steadystate inactivation, and slower recovery from inactivation can cause loss-of-function (LoF) (Mantegazza et al., 2005; Liao et al., 2010; Lossin et al., 2012; Catterall, 2014b; Vanoye et al., 2014; Wagnon et al., 2017; Yang et al., 2018; Zaman et al., 2018; Wengert et…”
BackgroundInfluentialPRRT2 controls neuronal excitability by negatively modulating Na+ channel 1.2/1.6 activity
Fruscione, F., Valente, P., Sterlini, B., Romei, A., Baldassari, S., Fadda, M., Prestigio, C., Giansante, G., Sartorelli, J., Rossi, P., et al. (2018) · Brain · doi:10.1093/brain/awy051 · Cited by 138
“2 a-subunit causative for a PRRT2-like phenotype with neonatal-infantile seizures show similar increases in Na + current (Heron et al., 2002; Scalmani et al., 2006; Liao et al., 2010).”
Sodium channelopathies of skeletal muscle and brain
Mantegazza, M., Cestèle, S., & Catterall, W. A. (2021) · Physiological Reviews · doi:10.1152/physrev.00025.2020 · Cited by 133
Gene Panel Testing in Epileptic Encephalopathies and Familial Epilepsies
Møller, R. S., Larsen, L. H. G., Johannesen, K. M., Talvik, I., Talvik, T., Vaher, U., Miranda, M. J., Farooq, M., Nielsen, J. E. K., Lavard Svendsen, L., et al. (2016) · Molecular Syndromology · doi:10.1159/000448369 · Cited by 133
Voltage-Gated Sodium Channels: Biophysics, Pharmacology, and Related Channelopathies
Galimberti, E. S., Gollob, M. H., & Darbar, D. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00124 · Cited by 141
Antiepileptic drug therapy: Does mechanism of action matter?
Brodie, M. J., Covanis, A., Gil‐Nagel, A., Lerche, H., Perucca, E., Sills, G. J., & White, H. S. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.05.025 · Cited by 147
“campus and cortex [22,23].”
Self-citationRecurrent and Non-Recurrent Mutations of SCN8A in Epileptic Encephalopathy
Wagnon, J. L., & Meisler, M. H. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00104 · Cited by 124
The phenotypic spectrum of SCN2A-related epilepsy
Reynolds, C., King, M. D., & Gorman, K. M. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.12.016 · Cited by 125
Sodium channels and the neurobiology of epilepsy
Oliva, M., Berkovic, S. F., & Petrou, S. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03631.x · Cited by 124
“Agedependent seizure resolution in BFNIS has been suggested to correlate with the developmental reorganization of the AIS where SCN2A is replaced by SCN8A in the distal AIS diminishing the influence of mutant SCN2A on AIS function (Liao et al., 2010).”
BackgroundSelf-citationRegulation of Thalamic and Cortical Network Synchrony by Scn8a
Makinson, C. D., Tanaka, B. S., Sorokin, J. M., Wong, J. C., Christian, C. A., Goldin, A. L., Escayg, A., & Huguenard, J. R. (2017) · Neuron · doi:10.1016/j.neuron.2017.01.031 · Cited by 118
“…was performed in the hippocampus because this region is a discrete brain region that is easily targeted by stereotaxic injection and is known to express high levels of Scn8a and the other major CNS VGSCs (Blumenfeld et al., 2009; Liao et al., 2010; Lorincz and Nusser, 2008; Makinson et al., 2014).”
Clinical spectrum of SCN2A mutations
Shi, X., Yasumoto, S., Kurahashi, H., Nakagawa, E., Fukasawa, T., Uchiya, S., & Hirose, S. (2011) · Brain and Development · doi:10.1016/j.braindev.2011.09.016 · Cited by 122
“[22] found an increase in neuronal firing caused by mutations M252V and V261M both present in BFNIS.”
Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice
Ogiwara, I., Miyamoto, H., Tatsukawa, T., Yamagata, T., Nakayama, T., Atapour, N., Miura, E., Mazaki, E., Ernst, S. J., Cao, D., et al. (2018) · Communications Biology · doi:10.1038/s42003-018-0099-2 · Cited by 113
A period of structural plasticity at the axon initial segment in developing visual cortex
Gutzmann, A., Ergül, N., Grossmann, R., Schultz, C., Wahle, P., & Engelhardt, M. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00011 · Cited by 117
“Concurrently, between P10 and 15 a specific enrichment of NaV 1.6 and KV channels occurs at the AIS (Liao et al., 2010), which might have direct consequences for AP firing.”
BackgroundInfluentialNeuronal mechanisms of mutations in SCN8A causing epilepsy or intellectual disability
Liu, Y., Schubert, J., Sonnenberg, L., Helbig, K. L., Hoei-Hansen, C. E., Koko, M., Rannap, M., Lauxmann, S., Huq, M., Schneider, M. C., et al. (2019) · Brain · doi:10.1093/brain/awy326 · Cited by 118
Self-citationLi, M., Jancovski, N., Jafar-Nejad, P., Burbano, L. E., Rollo, B., Richards, K., Drew, L., Sedo, A., Heighway, J., Pachernegg, S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci152079 · Cited by 115
“2) and is involved in the initiation and conduction of action potentials, particularly during early postnatal development when its expression is higher than that of other voltagegated sodium channel isoforms (9, 10).”
BackgroundSelf-citationEpileptic Encephalopathies: New Genes and New Pathways
Nieh, S. E., & Sherr, E. H. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0301-2 · Cited by 123
“Mutations of the SCN2A gene were originally described in association with benign familial neonatal-infantile seizures (BFNIS) [106-110], but patients with more severe infantile onset epileptic encephalopathy phenotypes have been reported [111] [112].”
BackgroundBender, A. C., Morse, R. P., Scott, R. C., Holmes, G. L., & Lenck-Santini, P.-P. (2012) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.11.022 · Cited by 112
“3 expression appears to decline during postnatal development [51,52].”
BackgroundPRRT2 Mutations are the major cause of benign familial infantile seizures
Schubert, J., Paravidino, R., Becker, F., Berger, A., Bebek, N., Bianchi, A., Brockmann, K., Capovilla, G., Bernardina, B. D., Fukuyama, Y., et al. (2012) · Human Mutation · doi:10.1002/humu.22126 · Cited by 111
“[Liao et al., 2010], could be an explanation.”
BackgroundSelf-citationPotassium channel genes and benign familial neonatal epilepsy
Maljevic, S., & Lerche, H. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63326-2.00002-8 · Cited by 115
“6, occupying the distal part of the axon (Liao et al., 2010).”
BackgroundSelf-citationWolff, M., Brunklaus, A., & Zuberi, S. M. (2019) · Epilepsia · doi:10.1111/epi.14935 · Cited by 105
PRRT2 mutations and paroxysmal disorders
Méneret, A., Gaudebout, C., Riant, F., Vidailhet, M., Depienne, C., & Roze, E. F. (2013) · European Journal of Neurology · doi:10.1111/ene.12104 · Cited by 105
Genetic Landscape of Common Epilepsies: Advancing towards Precision in Treatment
Thakran, S., Guin, D., Singh, P., Singh, P., Kukal, S., Rawat, C., Yadav, S., Kushwaha, S. S., Srivastava, A. K., Hasija, Y., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207784 · Cited by 118
Biological concepts in human sodium channel epilepsies and their relevance in clinical practice
Brunklaus, A., Du, J., Steckler, F., Ghanty, I. I., Johannesen, K. M., Fenger, C. D., Schorge, S., Baez‐Nieto, D., Wang, H., Allen, A., et al. (2020) · Epilepsia · doi:10.1111/epi.16438 · Cited by 98
Self-citationMutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia
Schwarz, N., Hahn, A., Bast, T., Müller, S., Löffler, H., Maljevic, S., Gaily, E., Prehl, I., Biskup, S., Joensuu, T., et al. (2016) · Journal of Neurology · doi:10.1007/s00415-015-7984-0 · Cited by 95
“6 channels with increasing maturation [7].”
BackgroundSelf-citationGenotype phenotype associations across the voltage-gated sodium channel family
Brunklaus, A., Ellis, R., Reavey, E., Semsarian, C., & Zuberi, S. M. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102608 · Cited by 92
Shavkunov, A. S., Wildburger, N. C., Nenov, M. N., James, T. F., Buzhdygan, T. P., Panova-Elektronova, N. I., Green, T. A., Veselenak, R. L., Bourne, N., & Laezza, F. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.445924 · Cited by 87
“Sections were then fixed in fresh acetone at 20 °C for 8–10min and dried at room temperature for 30 min, as described previously (24).”
Method“Neonatal” NaV1.2 reduces neuronal excitability and affects seizure susceptibility and behaviour
Gazina, E. V., Leaw, B. T. W., Richards, K. L., Wimmer, V. C., Kim, T. H., Aumann, T. D., Featherby, T. J., Churilov, L., Hammond, V. E., Reid, C. A., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu562 · Cited by 89
Self-citationTatsukawa, T., Raveau, M., Ogiwara, I., Hattori, S., Miyamoto, H., Mazaki, E., Itohara, S., Miyakawa, T., Montal, M., & Yamakawa, K. (2019) · Molecular Autism · doi:10.1186/s13229-019-0265-5 · Cited by 84
Shin, W., Kweon, H., Kang, R., Kim, D., Kim, K., Kang, M., Kim, S. Y., Hwang, S. N., Kim, J. Y., Yang, E., et al. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00145 · Cited by 77
Genomic biomarkers of SUDEP in brain and heart
Glasscock, E. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.09.019 · Cited by 95
“2 (SCN2A) channels which are expressed at nodes early in development [65,69].”
BackgroundPRRT2-related disorders: further PKD and ICCA cases and review of the literature
Becker, F., Schubert, J., Striano, P., Anttonen, A., Liukkonen, E., Gaily, E. K., Gerloff, C. P., Müller, S., Heußinger, N., Kellinghaus, C., et al. (2013) · Journal of Neurology · doi:10.1007/s00415-012-6777-y · Cited by 74
“2 in BFNIS (benign familial neonatal/ infantile seizures) [36].”
BackgroundSelf-citationBaasch, A., Hüning, I., Gilissen, C., Klepper, J., Veltman, J. A., Gillessen‐Kaesbach, G., Hoischen, A., & Lohmann, K. (2014) · Epilepsia · doi:10.1111/epi.12554 · Cited by 70
Pure haploinsufficiency for Dravet syndrome NaV1.1 (SCN1A) sodium channel truncating mutations
Bechi, G., Scalmani, P., Schiavon, E., Rusconi, R., Franceschetti, S., & Mantegazza, M. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2011.03346.x · Cited by 67
“6) (Boiko et al., 2003; Vacher et al., 2008; Liao et al., 2010).”
Ademuwagun, I. A., Rotimi, S. O., Syrbe, S., Ajamma, Y. U., & Adebiyi, E. F. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.600050 · Cited by 74
SCN2A-Related Epilepsy: The Phenotypic Spectrum, Treatment and Prognosis
Zeng, Q., Yang, Y., Duan, J., Niu, X., Chen, Y., Wang, D., Zhang, J., Chen, J., Yang, X., Li, J., et al. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.809951 · Cited by 74
Rama, S., Zbili, M., Bialowas, A., Fronzaroli‐Molinières, L., Ankri, N., Carlier, E., Marra, V., & Debanne, D. (2015) · Nature Communications · doi:10.1038/ncomms10163 · Cited by 71
Pellock, J. M., Arzimanoglou, A. A., D’Cruz, O., Holmes, G. L., Nordli, D. R., & Shinnar, S. (2017) · Epilepsia · doi:10.1111/epi.13859 · Cited by 70
Liang, L., Darbandi, S. F., Pochareddy, S., Gulden, F. O., Gilson, M. C., Sheppard, B. K., Sahagun, A., An, J., Werling, D. M., Rubenstein, J. L. R., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00949-0 · Cited by 69
“Two variants associated with benign infantile seizures—M252V and L1563V—exhibit biophysical changes only when expressed on 5N isoform [19, 27].”
BackgroundBegemann, A., Acuña, M. A., Zweier, M., Vincent, M., Steindl, K., Bachmann-Gagescu, R., Hackenberg, A., Abela, L., Plecko, B., Kroell-Seger, J., et al. (2019) · Molecular Medicine · doi:10.1186/s10020-019-0073-6 · Cited by 66
Mishra, V., Karumuri, B. K., Gautier, N. M., Liu, R., Hutson, T. N., Vanhoof-Villalba, S. L., Vlachos, I., Iasemidis, L., & Glasscock, E. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx104 · Cited by 60
Guerrini, R., Marini, C., & Mantegazza, M. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0267-0 · Cited by 63
Epileptogenic ion channel mutations: From bedside to bench and, hopefully, back again
Mantegazza, M., Rusconi, R., Scalmani, P., AVANZINI, G., & Franceschetti, S. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.08.003 · Cited by 61
“6 in myelinated axons (Scalmani et al., 006; Liao et al., 2010).”
Berg, A. T., Palac, H., Wilkening, G. N., Zelko, F. A. J., & Schust, L. F. (2020) · Epilepsia · doi:10.1111/epi.16750 · Cited by 60
“Scoliosis (2) 16/62 (26%) 2 (15%) 14 (29%)”
Léna, I., & Mantegazza, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-49392-7 · Cited by 60
Yamagata, T., Ogiwara, I., Mazaki, E., Yanagawa, Y., & Yamakawa, K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.013 · Cited by 57
Vacher, H., & Trimmer, J. S. (2012) · Epilepsia · doi:10.1111/epi.12032 · Cited by 57
“2 gating, leading to a gain-of-function and consequently neuronal hyperexcitability, only a few of these mutations are also associated with changes in trafficking (Scalmani et al., 2006; Xu et al., 2007b; Liao et al., 2010a,b).”
BackgroundSCN 2A channelopathies: Mechanisms and models
Hedrich, U. B. S., Lauxmann, S., & Lerche, H. (2019) · Epilepsia · doi:10.1111/epi.14731 · Cited by 67
Self-citationClinical and genetic spectrum of SCN2A-associated episodic ataxia
Schwarz, N., Bast, T., Gaily, E. K., Golla, G., Gorman, K. M., Griffiths, L. R., Hahn, A., Hukin, J., King, M. D., Korff, C. M., et al. (2019) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.03.001 · Cited by 60
Self-citationMutation screening of SCN2A in schizophrenia and identification of a novel loss-of-function mutation
Carroll, L. S., Woolf, R., Ibrahim, Y., Williams, H. J., Dwyer, S., Walters, J., Kirov, G., O’Donovan, M. C., & Owen, M. J. (2016) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000110 · Cited by 54
“, 2003) and have also shown a neocortical and hippocampal expression pattern that diminishes throughout neurodevelopment (Liao et al., 2010).”
BackgroundDendritic Integration Dysfunction in Neurodevelopmental Disorders
Nelson, A. D., & Bender, K. J. (2021) · Developmental Neuroscience · doi:10.1159/000516657 · Cited by 63
Wu, J., Li, Y., & Jiang, R. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004237 · Cited by 59
“For example, SCN2A (MIM: 182390) has been validated to be causative for autism (MIM: 209850) [43] and early infantile epileptic encephalopathy-11 (EIEE11, MIM: 613721) [44,45] but benign familial neonatalinfantile seizures-3 (BFIS3, MIM: 607745) [46,47].”
BackgroundPhysiology and Pathophysiology of Sodium Channel Inactivation
Ghovanloo, M.-R., Aimar, K., Ghadiry-Tavi, R., Yu, A., & Ruben, P. C. (2016) · Current topics in membranes · doi:10.1016/bs.ctm.2016.04.001 · Cited by 58
Brunklaus, A., & Lal, D. (2020) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14519 · Cited by 57
“showing that Scn2a is expressed early in axon initial segments of excitatory neurons, while Scn8a is not expressed early on but becomes the predominant channel over time.(37) SCN summary characteristics are detailed in Table 1.”
BackgroundQue, Z., Olivero-Acosta, M. I., Zhang, J., Eaton, M., Tukker, A. M., Chen, X., Wu, J., Xie, J., Xiao, T., Wettschurack, K. W., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0564-21.2021 · Cited by 53
“2, is strongly expressed in principal neurons of the central nervous system, including excitatory glutamatergic neurons of the cortex (Hu et al., 2009; Liao et al., 2010; Tian et al., 2014; Ye et al., 2018).”
BackgroundAlternative splicing potentiates dysfunction of early-onset epileptic encephalopathy SCN2A variants
Thompson, C. H., Ben‐Shalom, R., Bender, K. J., & George, A. L. (2020) · The Journal of General Physiology · doi:10.1085/jgp.201912442 · Cited by 54
“…it localizes to axon initial segments (AISs), nodes of Ranvier, and the somatodendritic compartment in the developing brain, gain-offunction variants are predicted to enhance network excitability (Hu et al., 2009; Liao et al., 2010; Tian et al., 2014; Yamagata et al., 2017; Spratt et al., 2019).”
BackgroundInfluentialRole of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance
Makinson, C. D., Tanaka, B. S., Lamar, T., Goldin, A. L., & Escayg, A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.03.014 · Cited by 50
“6 is detectable by P10 and reaches adult levels by the third postnatal week (Plummer et al., 1997; Liao et al., 2010).”
Models for discovery of targeted therapy in genetic epileptic encephalopathies
Maljevic, S., Reid, C. A., & Petrou, S. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14134 · Cited by 49
“6 channels, which emerge later in development, at the distal part of the AIS (Liao et al. 2010b).”
BackgroundSelf-citationThe developmental changes of Nav1.1 and Nav1.2 expression in the human hippocampus and temporal lobe
Wang, W., Takashima, S., Segawa, Y., Itoh, M., Shi, X., Hwang, S.-K., Nabeshima, K., Takeshita, M., & Hirose, S. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.083 · Cited by 47
“2), and these have indicated some possible correlation between the expression, developmental changes, and onset of epileptic symptoms (Liao et al., 2010; Ogiwara et al., 2007; Vacher et al., 2008).”
Neonatal Developmental and Epileptic Encephalopathies
Kosseifi, C. E., Cornet, M., & Cilio, M. R. (2019) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2019.08.006 · Cited by 50
“6 (SCN8A), which may account for the limited temporal expression of SCN2A-associated epilepsy.(25) Interestingly, mutations in the SCN8A gene may also lead to developmental and epileptic encephalopathy.”
BackgroundNeonatal epilepsies: Clinical management
Cornet, M., Sands, T. T., & Cilio, M. R. (2018) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2018.01.004 · Cited by 49
Fletcher, E. V., Kullmann, D. M., & Schorge, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.250225 · Cited by 49
Lauxmann, S., Boutry‐Kryza, N., Rivier, C., Mueller, S., Hedrich, U. B. S., Maljevic, S., Szepetowski, P., Lerche, H., & Lesca, G. (2013) · Epilepsia · doi:10.1111/epi.12241 · Cited by 43
Self-citationActivity of NaV1.2 promotes neurodegeneration in an animal model of multiple sclerosis
Schattling, B., Fazeli, W., Engeland, B., Liu, Y., Lerche, H., Isbrandt, D., & Friese, M. A. (2016) · JCI Insight · doi:10.1172/jci.insight.89810 · Cited by 44
“2 is known to be expressed by these cells (21).”
BackgroundSelf-citationEpilepsy and brain channelopathies from infancy to adulthood
Bartolini, E., Campostrini, R., Kiferle, L., Pradella, S., Rosati, E., Chinthapalli, K., & Palumbo, P. J. (2019) · Neurological Sciences · doi:10.1007/s10072-019-04190-x · Cited by 43
Functional correlates of clinical phenotype and severity in recurrent SCN2A variants
Berecki, G., Howell, K. B., Heighway, J., Olivier, N. B., Rodda, J., Overmars, I., Vlaskamp, D. R. M., Ware, T. L., Ardern‐Holmes, S. L., Lesca, G., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03454-1 · Cited by 43
Self-citationHereditary Channelopathies in Neurology
Jurkat‐Rott, K., Lerche, H., Weber, Y. G., & Lehmann‐Horn, F. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-9485-8_18 · Cited by 45
Self-citationRelationship of electrophysiological dysfunction and clinical severity in SCN2A-related epilepsies
Lauxmann, S., Verbeek, N. E., Liu, Y., Zaichuk, M., Müller, S., Lemke, J. R., van Kempen, M. J. A., Lerche, H., & Hedrich, U. B. S. (2018) · Human Mutation · doi:10.1002/humu.23619 · Cited by 39
Self-citationVoltage‐gated sodium channels in genetic epilepsy: up and down of excitability
Rusina, E., Simonti, M., Duprat, F., Cestèle, S., & Mantegazza, M. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15947 · Cited by 39
PRRT2 mutation in Japanese children with benign infantile epilepsy
Okumura, A., Shimojima, K. Y., Kubota, T., Abe, S., Yamashita, S., Imai, K., Okanishi, T., Enoki, H., Fukasawa, T., Tanabe, T., et al. (2012) · Brain and Development · doi:10.1016/j.braindev.2012.09.015 · Cited by 37
PRRT2: A major cause of infantile epilepsy and other paroxysmal disorders of childhood
Nobile, C., & Striano, P. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63326-2.00008-9 · Cited by 36
Mason, E. R., & Cummins, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072454 · Cited by 38
Ng, A. C., Chahine, M., Scantlebury, M. H., & Appendino, J. P. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12352-x · Cited by 37
“For example, the epilepsies due to SCN8A pathogenic variants have a later onset than those from SCN2A , which is in keeping with the finding that Na V 1.2 channels are expressed early in the axon initial segments but are eventually replaced by Na V 1.6 channels [144].”
InfluentialGenetics of neonatal-onset epilepsies
Cornet, M., & Cilio, M. R. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64029-1.00020-5 · Cited by 37
Heighway, J., Sedó, A., Garg, A., Eldershaw, L., Perreau, V. M., Berecki, G., Reid, C. A., Petrou, S., & Maljevic, S. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105622 · Cited by 39
“16 What happens when a disease variant causes different functional consequences for neonatal and adult transcript variants? This has been demonstrated in several SCN2A developmental and epileptic encephalopathy mutations [37-40, 54], most often portraying greater dysfunction in neonatal channel isoform.”
BackgroundSelf-citationCompromised function in the Nav1.2 Dravet syndrome mutation R1312T
Lossin, C., Shi, X., Rogawski, M. A., & Hirose, S. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.017 · Cited by 32
The phenotype and treatment of SCN2A ‐related developmental and epileptic encephalopathy
Kim, H. J., Yang, D., Kim, S. H., Kim, B., Kim, H. D., Lee, J. S., Choi, J. R., Lee, S., & Kang, H. (2020) · Epileptic Disorders · doi:10.1684/epd.2020.1199 · Cited by 34
Inherited Developmental and Epileptic Encephalopathies
Bartolini, E. (2021) · Neurology International · doi:10.3390/neurolint13040055 · Cited by 32
“2 channel, which is highly expressed from the birth [27].”
BackgroundGenetic Biomarkers in Epilepsy
Weber, Y. G., Nies, A. T., Schwab, M. G., & Lerche, H. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0262-5 · Cited by 34
Self-citationBernardo, S., Marchionni, E., Prudente, S., Liso, P. D., Spalice, A., Giancotti, A., Manganaro, L., & Pizzuti, A. (2017) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2017.01.014 · Cited by 27
Post-translational dysfunctions in channelopathies of the nervous system
Terragni, B., Scalmani, P., Franceschetti, S., Cestèle, S., & Mantegazza, M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.028 · Cited by 28
Impact of a family history of epilepsy on the diagnosis of epilepsy in southern Saudi Arabia
Babtain, F. A. (2013) · Seizure · doi:10.1016/j.seizure.2013.04.002 · Cited by 27
“For instance, benign familial neonatal seizures are detected soon after birth, with no structural brain abnormalities and a variable prognosis.(22,23) In our study, the mean age at seizure onset of the patients with FHE was 15 years, compared to 20 years for non-FHE patients.”
Clinical and Genetic Aspects of Epilepsy
Heron, S., & Mulley, J. (2011) · InTech eBooks · doi:10.5772/1138 · Cited by 24
Metadata
- Authors
- Liao, Y., Deprez, L., Maljevic, S., Pitsch, J., Claes, L., Hristova, D., Jordanova, A., Ala-Mello, S., Bellan-Koch, A., Blazevic, D., Schubert, S., Thomas, E. A., Petrou, S., Becker, A. J., De Jonghe, P., & Lerche, H.
- Affiliations
- Universität Ulm (DE)
- University of Antwerp (BE)
- University of Bonn (DE)
- Tokuda Hospital (BG)
- Florey Institute of Neuroscience and Mental Health (AU)
- The University of Melbourne (AU)
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-04-05
- Volume
- 133
- Issue
- 5
- Pages
- 1403-1414
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2130786711
- Cited by
- 185
- References
- 109
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 11 · 2023: 4 · 2022: 5 · 2021: 18 · 2020: 16 · 2019: 16 · 2018: 11 · 2017: 16 · 2016: 8 · 2015: 10 · 2014: 20 · 2013: 13 · 2012: 8
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Funders
- GlaxoSmithKline
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- Nav1.2 sodium channel, Nav1.6 sodium channel, gain-of-function, persistent sodium current, fast inactivation, axon initial segment, neuronal maturation, seizure remission, idiopathic epilepsy
- MeSH terms
- Adult, Aging, Animals, Axons, Base Sequence, Cell Line, Electrophysiology, Hippocampus, Humans, Immunohistochemistry, Infant, Infant, Newborn, Male, Mice, Inbred C57BL, Mutation, Nerve Tissue Proteins, Pedigree, RNA, Messenger, Sodium Channels, Protein Isoforms, Reverse Transcriptase Polymerase Chain Reaction, Epilepsy, Benign Neonatal, Mice, NAV1.2 Voltage-Gated Sodium Channel, NAV1.6 Voltage-Gated Sodium Channel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.